Showing results (21-30 of 102) with videos related to

Sort By:
Pageof 11
International Journal of Surgery Case Reports|March 9, 2024
Cytoreduction surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) as treatment choice of metastatic Urachal carcinomaGiorgio Micheletti, Vincenzo Ricchiuti, Ludovico Carbone, et al.
Anti-Cancer Drugs|July 16, 2019
Poor outcome for patients with gastric cancer and lung metastases treated with ramucirumab and paclitaxelGiandomenico Roviello, Silvia P Corona, Andrea G Multari, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 3, 2015
Angiogenesis inhibitors in gastric and gastroesophageal junction cancerGiandomenico Roviello, Roberto Petrioli, Luigi Marano, et al.
Case Reports in Oncology|December 19, 2013
A husband and a wife with simultaneous presentation of glioblastoma multiforme: a case reportGiandomenico Roviello, Roberto Petrioli, Alfonso Cerase, et al.
Journal of the American Dental Association (1939)|May 3, 2011
Osteonecrosis of the jaw in patients with cancer who received zoledronic acid and bevacizumabFilippo Francini, Alessandra Pascucci, Edoardo Francini, et al.
Anti-Cancer Drugs|June 9, 2015
Tolerability of cabazitaxel in patients with metastatic castration-resistant prostate cancer progressing after docetaxel and abiraterone acetate: a single-institution experienceEdoardo Francini, Anna I Fiaschi, Roberto Petrioli, et al.
Medicine|July 3, 2019
Is there still a place for vinorelbine in advanced metastatic castration resistant prostate cancer?Giandomenico Roviello, Silvia Paola Corona, Raffaele Conca, et al.
Cancer Biology & Therapy|September 30, 2015
An exceptional overall survival using bevacizumab beyond progression in a patient with non-small cell lung cancerGiandomenico Roviello, Edoardo Francini, Armando Perrella, et al.
Clinical Colorectal Cancer|March 18, 2018
Efficacy and Safety of Regorafenib With 2/1 Schedule for Patients ≥ 75 Years With Metastatic Colorectal Cancer (mCRC) After Failure of 2 Lines of ChemotherapyRoberto Petrioli, Martina Chirra, Luciana Messuti, et al.
Anti-Cancer Drugs|March 27, 2015
Three-weekly oxaliplatin combined with gemcitabine and capecitabine in the first-line treatment of patients with advanced biliary tract cancerRoberto Petrioli, Giandomenico Roviello, Anna I Fiaschi, et al.
Pageof 11